Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly (IRIDIA)

This study has been terminated.
(End of recruitment period)
Information provided by:
Assistance Publique - Hôpitaux de Paris Identifier:
First received: September 13, 2005
Last updated: September 29, 2009
Last verified: April 2008

Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment.

in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.

Condition Intervention
Myocardial Ischemia
Other: diagnosis reassessment
Other: Diagnosis strategy and subsequent therapeutic reassessment

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly

Resource links provided by NLM:

Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly [ Time Frame: during hospitalization ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months [ Time Frame: during hospitalization ] [ Designated as safety issue: Yes ]

Enrollment: 260
Study Start Date: November 2004
Study Completion Date: November 2006
Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
All patients are in that arms. They all receive the diagnosis reassessment strategy.
Other: diagnosis reassessment
Strategy of diagnosis reassessment following a decision tree.
Other Name: no other names to specified
Other: Diagnosis strategy and subsequent therapeutic reassessment
Performed by geriatricians, following a decision tree, based on medical history, electrocardiogram, cardiac echotomography and stress scintigraphy

Detailed Description:
not desired

Ages Eligible for Study:   75 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • patients 75 of age or older hospitalized in a geriatric service and suspect of coronary heart disease

Exclusion Criteria:

  • acute myocardial infarction
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00224575

Hopital Bichat
Paris, France, 75018
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Principal Investigator: legrain sylvie APHP
  More Information

No publications provided

Responsible Party: Zakia IDIR, Department Clinical Rechearch of Developpement Identifier: NCT00224575     History of Changes
Other Study ID Numbers: AOM03099 
Study First Received: September 13, 2005
Last Updated: September 29, 2009
Health Authority: France: Ministry of Health

Keywords provided by Assistance Publique - Hôpitaux de Paris:

Additional relevant MeSH terms:
Coronary Artery Disease
Coronary Disease
Heart Diseases
Myocardial Ischemia
Arterial Occlusive Diseases
Cardiovascular Diseases
Vascular Diseases processed this record on February 10, 2016